endoglycosidaseh (New England Biolabs)


Name:
O Glycosidase
Description:
O Glycosidase 10 000 000 units
Catalog Number:
p0733l
Price:
550
Category:
Glycosidases
Size:
10 000 000 units
|
Buy from Supplier |
Structured Review

O Glycosidase 10 000 000 units
https://www.bioz.com/result/endoglycosidaseh/product/New England Biolabs
Average 95 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Mycolactone reveals the substrate-driven complexity of Sec61-dependent transmembrane protein biogenesis"
Article Title: Mycolactone reveals the substrate-driven complexity of Sec61-dependent transmembrane protein biogenesis
Journal: Journal of Cell Science
doi: 10.1242/jcs.198655

Figure Legend Snippet: The large N-terminal domain of the type I TMP VCAM1 results in a complete block of its membrane integration by mycolactone. (A) VCAM1 translated in the absence or presence of mycolactone (MYC) and treated with EndoglycosidaseH (EndoH). (B) VCAM1 and VCAM1 60 constructs (wild type and S707L/S707L* mutants) used in this study. (C) VCAM1 60 and a version containing an artificial N-glycosylation site (C52N) translated in the absence or presence of mycolactone, without or without EndoH. (D) VCAM1 60 and a variant with a more hydrophobic TMD (VCAM1 60 S707L* ) translated in the absence or presence of mycolactone, without or without subsequent EndoH treatment. Estimated TMD hydrophobicities (kcal/mol) are indicated in D. Graph shows the reduction in the amount of ‘+g’ VCAM1 60 and VCAM1 60 S707L* in the presence of mycolactone, relative to control samples, as described in the legend to Fig. 1 . is also shown in D (graph). The statistical test performed was one-way ANOVA. Error bars show mean±s.d. VCAM1, n =3 VCAM1 60 , n =4; VCAM1 60 S707L* , n =3). P -values are as defined in Fig. 1 legend. (E) Translation of VCAM1, VCAM1 60 and the secretory protein cecropin, possessing a C-terminal opsin tag (CecOPG2), performed with increasing concentrations of CAM741 or an equivalent volume of DMSO (‘−’). (F) VCAM1 60 and VCAM1 60 S707L* translated in the absence or presence of 250 nM CAM741. Other symbols are as defined in Fig. 1 legend.
Techniques Used: Blocking Assay, Construct, Variant Assay

Figure Legend Snippet: ER integration of the type I TMP CD3δ in the presence of mycolactone is driven by its TMD. (A) Truncated mRNAs coding for CD3δ (top panel) and CD3δ D111L (bottom panel) and lacking stop codons translated in the absence or presence of mycolactone (MYC) without puromycin-mediated release. The nascent chain length of each truncation is shown, as well as the number of residues synthesised C-terminal to the TMD to provide an estimate of its distance from the peptidyl-transferase centre (PTC) of the ribosome. Truncations where all or part of the TMD is likely obscured by the ribosomal exit tunnel (based on Cabrita et al., 2016 ) are indicated by the bracketed area. CD3δ 158 is encompassed by a dashed bracket, since its TMD is likely on the border of having just fully emerged from the ribosomal exit tunnel. Arrowheads indicate maximal glycosylation resulting from the TMD-dependent rescue of integration in the presence of mycolactone. (B) Versions of (i) CD3δ and (ii) CD3δ D111L lacking signal sequences (ΔSS) translated in the absence and presence of mycolactone, without or without subsequent EndoglycosidaseH (EndoH) treatment. (C) Predicted mechanism of type I TMP integration in the absence (i) and presence (ii) of mycolactone. Other symbols are as defined in Fig. 1 legend. ‘+g’, glycosylated; ‘0g’, non-glycosylated; ‘C’, C-terminus; FL, full length; ‘N’, N-terminus.
Techniques Used:
![... of mycolactone (MYC), followed by subsequent treatment with EndoglycosidaseH (EndoH). (B) Graph shows change in the amount ... Mycolactone does not interfere with type III TMP integration. (A) Translation of GypC in the absence or presence of mycolactone (MYC), followed by subsequent treatment with EndoglycosidaseH (EndoH). (B) Graph shows change in the amount of glycosylated (+g) GypC and related constructs in the presence of mycolactone, relative to control samples as described in the legend to Fig. 1 . The statistical test performed was one-way ANOVA. Error bars show mean±s.d. GypC, n =10; others, n =3. Ns, not significant. (C) Estimated TMD hydrophobicities (kcal/mol) of GypC and related constructs. (D) Translation of two variants of GypC with reduced TMD hydrophobicity. (E) GypC truncations lacking stop codons. For crosslinking experiments, truncations contained a single artificially introduced cysteine residue at either position 52 or 84, as denoted by an asterisk. (F) Truncated GypC chains synthesised in the absence or presence of mycolactone without puromycin-mediated release. The glycosylation of nascent chains when still attached to the ribosome (indicated by ‘peptRNA’) was observed. (G) Truncated GypC chains containing a single cysteine residue [either *(52) or *(84)] synthesised in the absence or presence of mycolactone without puromycin-mediated release to generate membrane integration intermediates. Samples were treated with the crosslinking reagent BMH, subjected to extraction with alkaline sodium carbonate, and analysed by SDS-PAGE. Adducts between the nascent chain and Sec61β (xSec61β) or the nascent chain and Sec61α/Sec61α and Sec61β (xSec61α/αβ) are indicated (see also Fig. S3B ). Mycolactone-sensitive adducts are indicated by arrowheads. Other symbols are as defined in Fig. 1 legend. FL, full length.](https://storage.googleapis.com/bioz_article_images/PMC5399781/joces-130-198655-g4.jpg)
Figure Legend Snippet: Mycolactone does not interfere with type III TMP integration. (A) Translation of GypC in the absence or presence of mycolactone (MYC), followed by subsequent treatment with EndoglycosidaseH (EndoH). (B) Graph shows change in the amount of glycosylated (+g) GypC and related constructs in the presence of mycolactone, relative to control samples as described in the legend to Fig. 1 . The statistical test performed was one-way ANOVA. Error bars show mean±s.d. GypC, n =10; others, n =3. Ns, not significant. (C) Estimated TMD hydrophobicities (kcal/mol) of GypC and related constructs. (D) Translation of two variants of GypC with reduced TMD hydrophobicity. (E) GypC truncations lacking stop codons. For crosslinking experiments, truncations contained a single artificially introduced cysteine residue at either position 52 or 84, as denoted by an asterisk. (F) Truncated GypC chains synthesised in the absence or presence of mycolactone without puromycin-mediated release. The glycosylation of nascent chains when still attached to the ribosome (indicated by ‘peptRNA’) was observed. (G) Truncated GypC chains containing a single cysteine residue [either *(52) or *(84)] synthesised in the absence or presence of mycolactone without puromycin-mediated release to generate membrane integration intermediates. Samples were treated with the crosslinking reagent BMH, subjected to extraction with alkaline sodium carbonate, and analysed by SDS-PAGE. Adducts between the nascent chain and Sec61β (xSec61β) or the nascent chain and Sec61α/Sec61α and Sec61β (xSec61α/αβ) are indicated (see also Fig. S3B ). Mycolactone-sensitive adducts are indicated by arrowheads. Other symbols are as defined in Fig. 1 legend. FL, full length.
Techniques Used: Construct, SDS Page

Figure Legend Snippet: Mycolactone traps headfirst-inserting type II TMPs in an N-lumenal–C-cytosolic topology. (A) ASGPR H1 and ASGPR H1Δ. Translation of ASGPR H1 (B) and ASGPR H1Δ (C) performed in the absence or presence of mycolactone (MYC), followed by treatment with EndoglycosidaseH (EndoH). Membrane fractions were subjected to extraction with alkaline sodium carbonate prior to analysis. (D) Graph shows the amount of glycosylated (‘+g’) and non-glycosylated (‘0g’) ASGPR H1 and ASGPR H1Δ in the presence of mycolactone, relative to control samples. These values were determined by dividing the quantity of ‘+g’ or ‘0g’ substrate obtained in the presence of mycolactone by the quantity of '+g' or '0g' substrate obtained in the absence of mycolactone and are expressed as percentages. Dashed red line represents the value for comparative material for samples treated with a vehicle control. The statistical test performed was two-way ANOVA. Error bars show mean±s.d. ( n =3). P -values are as defined in Fig. 1 legend. (E) Diagram showing type II TMPs that insert using a hairpin mechanism (i) or a headfirst/inversion mechanism (ii), as well as the headfirst insertion of type III TMPs (iii). Faded steps represent those that are prevented by mycolactone. Dashed arrow shows the predicted route taken by headfirst-inserting type II TMPs when inversion is prevented by mycolactone.
Techniques Used:

Figure Legend Snippet: Mycolactone sensitivity is dependent upon which TMD-flanking region is translocated. (A) A chimeric protein containing Ii downstream of a pre-prolactin (PPL) signal sequence (i) and the two topologies it might assume following integration into RMs, depending on whether the region that is translocated is N-terminal (ii) or C-terminal (iii) of the TMD. (B) Translation of PPL-Ii and PPL-Ii G47L Q48L* in the absence or presence of mycolactone (MYC), followed by treatment with EndoglycosidaseH (EndoH). Samples were analysed following immunoprecipitation of Ii. (C) Graph showing the amount of signal-cleaved (‘sc’) or glycosylated (‘+g’) substrate in the presence of mycolactone relative to control samples. These values were determined by dividing the quantity of ‘sc’ or ‘+g’ substrate obtained in the presence of mycolactone by the quantity of ‘sc’ or ‘+g’ substrate obtained in the absence of mycolactone and are expressed as percentages. The statistical test performed was two-way ANOVA. Error bars show mean±s.d. ( n =3). P -values and other symbols are as defined in Fig. 1 legend.
Techniques Used: Sequencing, Immunoprecipitation
![... 125 (F), which was followed by treatment with EndoglycosidaseH (EndoH). (G) Ii truncations used in this study. ... Mycolactone efficiently blocks type II TMP integration. (A) Full-length Ii (wild type and G47L Q48L mutant) and the Ii 125 truncation used in this study. (B) Estimated TMD hydrophobicities (kcal/mol) of Ii and Ii G47L Q48L . (C) Graph shows the reduction in the amount of glycosylated (+g) Ii and related constructs in the presence of mycolactone (MYC), relative to control samples as described in the legend to Fig. 1 . The statistical test performed was one-way ANOVA. Error bars show mean±s.d. ( n =3). P -values are as defined in Fig. 1 legend. Translation in the absence or presence of mycolactone performed using Ii (D), Ii G47L Q48L (E) and Ii 125 (F), which was followed by treatment with EndoglycosidaseH (EndoH). (G) Ii truncations used in this study. For crosslinking experiments, truncations contained either a native cysteine residue (C28) or one that was artificially introduced [*(50)]. A truncated version of TNFα used for crosslinking analysis (as described in MacKinnon et al., 2014 ) is shown for comparative purposes. Crosslinking was performed on Ii truncations (H) and Ii 125 *(50) (I) and the resulting adducts are labelled as described in the Fig. 4 G legend. Other symbols are as defined in Fig. 1 legend. Puro, puromycin.](https://storage.googleapis.com/bioz_article_images/PMC5399781/joces-130-198655-g5.jpg)
Figure Legend Snippet: Mycolactone efficiently blocks type II TMP integration. (A) Full-length Ii (wild type and G47L Q48L mutant) and the Ii 125 truncation used in this study. (B) Estimated TMD hydrophobicities (kcal/mol) of Ii and Ii G47L Q48L . (C) Graph shows the reduction in the amount of glycosylated (+g) Ii and related constructs in the presence of mycolactone (MYC), relative to control samples as described in the legend to Fig. 1 . The statistical test performed was one-way ANOVA. Error bars show mean±s.d. ( n =3). P -values are as defined in Fig. 1 legend. Translation in the absence or presence of mycolactone performed using Ii (D), Ii G47L Q48L (E) and Ii 125 (F), which was followed by treatment with EndoglycosidaseH (EndoH). (G) Ii truncations used in this study. For crosslinking experiments, truncations contained either a native cysteine residue (C28) or one that was artificially introduced [*(50)]. A truncated version of TNFα used for crosslinking analysis (as described in MacKinnon et al., 2014 ) is shown for comparative purposes. Crosslinking was performed on Ii truncations (H) and Ii 125 *(50) (I) and the resulting adducts are labelled as described in the Fig. 4 G legend. Other symbols are as defined in Fig. 1 legend. Puro, puromycin.
Techniques Used: Mutagenesis, Construct
2) Product Images from "Endo-?-N-acetylglucosaminidases from Infant Gut-associated Bifidobacteria Release Complex N-glycans from Human Milk Glycoproteins *"
Article Title: Endo-?-N-acetylglucosaminidases from Infant Gut-associated Bifidobacteria Release Complex N-glycans from Human Milk Glycoproteins *
Journal: Molecular & Cellular Proteomics : MCP
doi: 10.1074/mcp.M112.018119

Figure Legend Snippet: Endoglycosidase activity found in Bifidobacterium isolates. A , deglycosylation of RNaseB by B. infantis ATCC 15697 over time. B–D , overnight incubation with RNaseB was evaluated for other isolates of B. longum ( B ), B. infantis ( C ), or B. breve ( D ). E , phylogenetic representation of predicted endoglycosidase protein sequences found in bifidobacterial isolates. C: control reactions.
Techniques Used: Activity Assay, Incubation
3) Product Images from "Tsetse salivary glycoproteins are modified with paucimannosidic N-glycans, are recognised by C-type lectins and bind to trypanosomes"
Article Title: Tsetse salivary glycoproteins are modified with paucimannosidic N-glycans, are recognised by C-type lectins and bind to trypanosomes
Journal: bioRxiv
doi: 10.1101/2020.06.25.172007
![... (young, unfed) flies, before and after digestion with exoglycosidases. Aliquots of the total PNGase F-released 2-AB-labeled N ... Tsetse fly salivary glycoproteins are composed mainly of paucimannose and oligomannose glycans. [A] Profile of salivary N -glycans from teneral (young, unfed) flies, before and after digestion with exoglycosidases. Aliquots of the total PNGase F-released 2-AB-labeled N -glycan pool were either undigested (i) or incubated with a range of exoglycosidases (ii-iv). (i) Undig, before digestion; (ii) GUH, Streptococcus pneumonia in E. coli β-N-acetylglucosaminidase; (iii) JBM, Jack bean α-Mannosidase; (iv) bkF, Bovine kidney α-fucosidase. Following digestion, the products were analysed by HILIC-(U)HPLC. Peaks labelled A correspond to the product of complete digestion with JBM; those labelled with an asterisk refer to buffer contaminants. The percent areas and structures of the different glycans are listed in Table 1 . [B] Positive-ion ESI-MS spectrum of procainamide-labelled N -glycans from teneral tsetse fly saliva. Numbers refer to the structures shown in Table 1 . Asterisk (*) refers to m/z 1130.55 as [M+2H] 2+ ion. Green circle, mannose; blue square, N -Acetylglucosamine; red triangle, fucose; Proc, procainamide.](https://www.biorxiv.org/content/biorxiv/early/2020/06/27/2020.06.25.172007/F1.large.jpg)
Figure Legend Snippet: Tsetse fly salivary glycoproteins are composed mainly of paucimannose and oligomannose glycans. [A] Profile of salivary N -glycans from teneral (young, unfed) flies, before and after digestion with exoglycosidases. Aliquots of the total PNGase F-released 2-AB-labeled N -glycan pool were either undigested (i) or incubated with a range of exoglycosidases (ii-iv). (i) Undig, before digestion; (ii) GUH, Streptococcus pneumonia in E. coli β-N-acetylglucosaminidase; (iii) JBM, Jack bean α-Mannosidase; (iv) bkF, Bovine kidney α-fucosidase. Following digestion, the products were analysed by HILIC-(U)HPLC. Peaks labelled A correspond to the product of complete digestion with JBM; those labelled with an asterisk refer to buffer contaminants. The percent areas and structures of the different glycans are listed in Table 1 . [B] Positive-ion ESI-MS spectrum of procainamide-labelled N -glycans from teneral tsetse fly saliva. Numbers refer to the structures shown in Table 1 . Asterisk (*) refers to m/z 1130.55 as [M+2H] 2+ ion. Green circle, mannose; blue square, N -Acetylglucosamine; red triangle, fucose; Proc, procainamide.
Techniques Used: Labeling, Incubation, Hydrophilic Interaction Liquid Chromatography
Related Articles
Recombinant:Article Title: The Rim101 Pathway Is Involved in Rsb1 Expression Induced by Altered Lipid Asymmetry Article Snippet: For detecting HA-Rim101, Myc-Rim101-531, and genomic-encoded Rsb1-HA proteins, we enhanced the signal of the anti-HA antibody Y-11 and the anti-Myc antibody PL-14 using Can Get Signal Immunoreaction Enhancer Solution (Toyobo), according to the manufacturer's manual. .. Proteins (5 μl) in 1× SDS sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, and a trace amount of bromophenol blue containing 5% 2-mercaptoethanol) were diluted with 40 μl 0.05 M sodium citrate (pH 5.5) containing 1 mM phenylmethylsulfonyl fluoride, and treated at 37°C for 1 h with 1000 U of other:Article Title: Stress Tolerance of Misfolded Carboxypeptidase Y Requires Maintenance of Protein Trafficking and Degradative Pathways Article Snippet: Quantification of the data was performed after digestion by endoglycosidase H (Endo H), an enzyme that specifically cleaves N-linked carbohydrates. Incubation:Article Title: A Particle-Associated Glycoprotein Signal Peptide Essential for Virus Maturation and Infectivity Article Snippet: Viral proteins were precipitated as described earlier ( , ), using rabbit antisera directed against recombinant FV proteins and specific for Env ( ) and Gag ( ). .. For glycosidase treatment, protein A-Sepharose eluates were denatured by boiling in 0.5% SDS–1% β-mercaptoethanol and subsequently incubated with Nucleic Acid Electrophoresis:Article Title: A Particle-Associated Glycoprotein Signal Peptide Essential for Virus Maturation and Infectivity Article Snippet: Viral proteins were precipitated as described earlier ( , ), using rabbit antisera directed against recombinant FV proteins and specific for Env ( ) and Gag ( ). .. For glycosidase treatment, protein A-Sepharose eluates were denatured by boiling in 0.5% SDS–1% β-mercaptoethanol and subsequently incubated with Polyacrylamide Gel Electrophoresis:Article Title: A Particle-Associated Glycoprotein Signal Peptide Essential for Virus Maturation and Infectivity Article Snippet: Viral proteins were precipitated as described earlier ( , ), using rabbit antisera directed against recombinant FV proteins and specific for Env ( ) and Gag ( ). .. For glycosidase treatment, protein A-Sepharose eluates were denatured by boiling in 0.5% SDS–1% β-mercaptoethanol and subsequently incubated with |